Molecular Therapy: Nucleic Acids

Print ISSN: 2162-2531

Electronic ISSN: None

Basic Info

  • Publisher: Elsevier
  • Country: united states
  • Date added to EuroPub 2018/Feb/01

Subject & More

LCC Subject Category: Engineering, Medicine, Genetics, Pharmacology

Publisher's keywords: Development of Therapeutics, Vector Development, RNA Based Therapeutics, Gene Modifying Agents, Safety Studies

  • Language of fulltext: english
  • Time from submission to publication: 20 Weeks

Publication Charges

  • Article Processing Charges (APCs): Yes, 3200 GBP
  • Submission charges: No
  • Waiver policy for charges? No

Open access & licensing

  • Type of License: CC BY-NC-ND
  • Open Access Statement: Yes
  • Year open access content began: 2012
  • Does the author retain unrestricted copyright? False
  • Does the author retain publishing rights? False

Best practice polices

  • Permanent article identifier: DOI
  • Content digitally archived in: CLOCKSS, Portico,
  • Deposit policy registered in: Sherpa/Romeo

Impact Factor